We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Recommendations for HIV Testing

By HospiMedica staff writers
Posted on 11 Oct 2006
The U.S. More...
Centers of Disease Control and Prevention (CDC, Atlanta, GA, USA) have revised their recommendations for human immunodeficiency virus (HIV) testing, now advocating routine voluntary HIV screening as a normal part of medical practice, similar to screening for other treatable conditions. HIV screening would be routine in all medical settings for patients from the ages of 13 to 64.

Effective September 2006, the "Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Healthcare Settings” aim to make HIV testing a routine part of medical care in addition to expanding the gains made in diagnosing HIV infection among pregnant women. The recommendations replace the CDC's 1993 recommendations and they update portions of the 2001 revised guidelines.

The objectives of these recommendations are to increase HIV screening of patients, including pregnant women, in healthcare settings; to foster earlier detection of HIV infection; to identify and counsel people with unrecognized HIV infection and to link them to clinical and prevention services; and to further reduce perinatal transmission of HIV in the United States.

The HIV-testing recommendations are intended for all healthcare providers in the public and private sectors, including those working in hospital emergency departments, urgent care clinics, inpatient services, substance-abuse treatment clinics, public health clinics, community clinics, correctional healthcare facilities, and primary care settings. The recommendations address HIV testing in healthcare settings only. They do not modify existing guidelines concerning HIV counseling, testing, and referral for people at high risk for HIV who seek or receive HIV testing in nonclinical settings (e.g., community-based organizations, outreach settings, or mobile vans). HIV screening will be included in the routine panel of prenatal screening tests for all pregnant women.

HIV screening is recommended after the patient is notified that testing will be performed unless the patient declines (opt-out screening). People at high risk for HIV infection should be screened for HIV at least annually. Separate, written consent for HIV testing should not be required; general consent for medical care should be considered sufficient to encompass consent for HIV testing. Repeat screening in the third trimester is recommended in certain jurisdictions with elevated rates of HIV infection among pregnant women.



Related Links:
Centers of Disease Control and Prevention

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.